Mainz Biomed N.V. (QUCY)
NASDAQ: QUCY · Real-Time Price · USD
0.502
-0.038 (-7.04%)
At close: Apr 28, 2026, 4:00 PM EDT
0.498
-0.004 (-0.76%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Mainz Biomed Employees
As of December 31, 2024, Mainz Biomed had 26 total employees, including 19 full-time and 7 part-time employees. The number of employees decreased by 45 or -63.38% compared to the previous year.
Employees
26
Change (1Y)
-45
Growth (1Y)
-63.38%
Revenue / Employee
$20,657
Profits / Employee
-$623,489
Market Cap
6.28M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 26 | -45 | -63.38% |
| Dec 31, 2023 | 71 | 7 | 10.94% |
| Dec 31, 2022 | 64 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Inotiv | 2,046 |
| MDxHealth | 364 |
| Biodesix | 334 |
| XWELL | 280 |
| Exagen | 220 |
| Precipio | 71 |
| bioAffinity Technologies | 57 |
| Advanced Biomed | 31 |
QUCY News
- 6 weeks ago - Quantum Cyber (f/k/a Mainz Biomed) Announces Stock Ticker Symbol Change to NASDAQ: QUCY - GlobeNewsWire
- 6 weeks ago - Mainz Biomed Announces Appointment of Robert Liscouski as Chairman of the Board of Directors - GlobeNewsWire
- 3 months ago - Mainz Biomed to Present Results of Pancreatic Cancer Verification Study at AACR 2026 Annual Meeting - GlobeNewsWire
- 5 months ago - Mainz Biomed and OncoVanguard8 Enter into Agreement to bring ColoAlert to South America - GlobeNewsWire
- 5 months ago - Mainz Biomed Showcases Innovative Cancer Detection Solutions at MEDICA 2025 - GlobeNewsWire
- 6 months ago - Mainz Biomed to Attend the 38th Annual Meeting of the Gastroenterological Working Group of Rhineland-Palatinate (GARPS) - GlobeNewsWire
- 7 months ago - Mainz Biomed Reports Topline Results from Feasibility Study of Biomarker Panel in Pancreatic Cancer Project - GlobeNewsWire
- 8 months ago - Mainz Biomed Announces Registration of ColoAlert in the United Kingdom - GlobeNewsWire